Novel Furo-pyridine Derivatives
156.9, 162.5 (3 s, C-2, C-3, i-Ph) ppm. IR (KBr): ν = 3090–3030
0.61 mmol), CuI (29 mg, 0.15 mmol), 2-methylbut-3-yn-2-ol
˜
(=C–H), 2960–2870 (C–H), 2230–2205 (CϵC), 1600–1585 (C=C) (309 mg, 3.67 mmol) in D M F (14 mL) and diisopropylamine
cm–1. MS (EI, 80 eV, 70 °C): m/z (%) = 409 (12) [M]+, 394 (14)
[M – CH3]+, 318 (2) [M – C7H7]+, 91 (100) [C7H7]+, 65 (4) [C6H5]+.
HRMS calcd. for C25H22F3NO: 409.16535; found 409.16488.
(7 mL) provided the crude product. Column chromatography on
silica gel (hexane/ethyl acetate, 10:1) afforded 924 mg (96%) of 3e
1
as a colourless solid; m.p. 56–58 °C. H NMR (CDCl3, 500 MHz):
δ = 1.37 [s, 9 H, C(CH3)3], 1.63 (s, 6 H, Me), 4.08 (s, 3 H, OMe),
7.48 (s, 1 H, 5-H) ppm; OH signal could not be detected. 13C NMR
(CDCl3, 126 MHz): δ = 28.9, 38.3 [q, s, C(CH3)3], 31.0 (q, Me),
65.7 (s, C-2Ј), 60.9 (q, OMe), 76.7, 103.8 (2 s, CϵC), 121.4 (q, 1JCF
2-Ethyl-3-methoxy-4-(phenylethynyl)-6-(trifluoromethyl)pyridine
(3a): According to method A, pyridyl nonaflate 1a (100 mg,
0.198 mmol), Pd(OAc)2 (2.3 mg, 0.01 mmol), PPh3 (10.2 mg,
0.039 mmol), CuI (1.9 mg, 0.01 mmol), phenylacetylene (30 mg,
0.29 mmol) in DMF (0.70 mL) and diisopropylamine (0.35 mL)
provided the crude product. Column chromatography on silica gel
(hexane/ethyl acetate, 40:1) afforded 43 mg (72%) of 3a as a light
yellow solid; m.p. 66–68 °C. 1H NMR (CDCl3, 500 MHz): δ = 1.29,
2.91 (t, q, J = 7.5 Hz, 3 H, 2 H, Et), 4.14 (s, 3 H, OMe), 7.38–7.55
(m, 5 H , Ph), 7.59 (s, 1 H , 5-H ) p pm. 13C N M R (CD Cl3,
126 MHz): δ = 12.8, 26.1 (q, t, Et), 61.2 (q, OMe), 83.2, 99.0 (2 s,
3
2
= 274 Hz, CF3), 122.9 (dq, JCF = 2.6 Hz, C-5), 140.1 (q, JCF
=
35 Hz, C-6), 123.8, 157.8, 162.6 (3 s, C-2, C-3, C-4) ppm. IR (KBr):
ν = 3360 (O–H), 3080–3060 (=C–H), 2990–2865 (C–H), 2250–2225
˜
(CϵC), 1600–1585 (C=C) cm–1. C16H20F3NO2 (315.3): calcd. C
60.94, H 6.39, N 4.44; found C 60.93, H 6.43, N 4.46.
3-(Benzyloxy)-2-tert-butyl-4-(3-methoxyprop-1-ynyl)-6-(trifluoro-
methyl)pyridine (3f): According to method A, pyridyl nonaflate 1d
(412 mg, 0.68 mmol), Pd(OAc)2 (8 mg, 0.04 mmol), PPh3 (36 mg,
0.14 mmol), CuI (6 mg, 0.04 mmol), methyl propargyl ether
(56 mg, 0.81 mmol) in D M F (3 mL) and diisopropylamine
(1.5 mL) provided the crude product. Column chromatography on
silica gel (hexane/ethyl acetate, 40:1) afforded 191 mg (75%) of 3f
1
3
CϵC), 121.5 (q, JCF = 274 Hz, CF3), 121.9 (dq, JCF = 2.8 Hz,
C-5), 122.4, 123.6, 128.7, 129.6, 131.7 (2 s, 3 d, C-4, Ph), 141.9 (q,
2JCF = 35.6 Hz, C-6), 156.2, 158.9 (2 s, C-2, C-3) ppm. IR (KBr):
ν = 3000–2870 (=C–H, C–H), 2220 (CϵC), 1600–1540 (C=C)
˜
cm–1. MS (EI, 80 eV, 70 °C): m/z (%) = 305 (100) [M]+, 276 (32)
[M – C2H5]+. C17H14F3NO (305.3): calcd. C 66.88, H 4.62, N 4.59;
found C 66.72, H 4.39, N 4.40.
1
as a colourless oil. H NMR (CDCl3, 500 MHz): δ = 1.41 [s, 9 H,
C(CH3)3], 3.35 (s, 3 H, OMe), 4.23, 5.37 (2 s, 2 H, 2 H, OCH2),
7.33–7.53 (m, 5 H, Ph), 7.57 (s, 1 H, 5-H) ppm. 13C NMR (CDCl3,
126 MHz): δ = 29.1, 38.5 [q, s, C(CH3)3], 58.0 (q, OMe), 60.2, 75.1
2-Phenyl-3-methoxy-4-(phenylethynyl)-6-(trifluoromethyl)pyridine
(3c): According to method A, pyridyl nonaflate 1c (100 mg,
0.181 mmol), Pd(OAc)2 (2.0 mg, 0.009 mmol), PPh3 (9.4 mg,
0.036 mmol), CuI (1.7 mg, 0.009 mmol), phenylacetylene (23 mg,
0.23 mmol) in DMF (0.8 mL) and diisopropylamine (0.4 mL) pro-
vided the crude product. Column chromatography on silica gel
(hexane/ethyl acetate, 40:1) afforded 48 mg (75%) of 3c as a colour-
less solid; m.p. 122 °C. 1H NMR (CDCl3, 500 MHz): δ = 3.91 (s,
3 H, OMe), 7.39–7.50 (m, 6 H, Ph), 7.72 (s, 1 H, 5-H), 7.61–8.01
(m, 4 H, Ph) ppm. 13C NMR (CDCl3, 126 MHz): δ = 61.2 (q,
1
(2 t, OCH2), 80.2, 95.9 (2 s, CϵC), 121.5 (q, JCF = 273 Hz, CF3),
3
122.5 (s, C-4), 123.0 (dq, JCF = 2.8 Hz, C-5), 127.4, 128.2, 128.5
2
(3 d, Ph), 140.5 (q, JCF = 30 Hz, C-6), 136.6, 156.6, 162.9 (3 s, i-
Ph, C-2, C-3) ppm. IR (film): ν = 3095–3030 (=C–H), 2960–2820
˜
(C–H), 2235–2225 (CϵC), 1590–1540 (C=C) cm–1. MS (EI, 80 eV,
80 °C): m/z (%) = 377 (1) [M]+, 362 (1) [M – CH3]+, 346 (2) [M –
OCH3]+, 91 (100) [C7H7]+, 69 (21) [CF3]+, 57 (5) [C4H9]+. HRMS
calcd. for C21H22F3NO2: 377.16026; found 377.16144.
3
OMe), 83.2, 99.0 (2 s, CϵC), 121.8 (dq, JCF = 2.9 Hz, C-5), 123.3
2-tert-Butyl-4-(phenylethynyl)-6-(trifluoromethyl)-3-[2-(trimethylsil-
yl)ethoxy]pyridine (3h): According to method A, pyridyl nonaflate
1e (212 mg, 0.35 mmol), Pd(OAc)2 (7 mg, 0.02 mmol), PPh3
(18 mg, 0.07 mmol), CuI (4 mg, 0.02 mmol), phenylacetylene
(42 mg, 0.42 mmol) in D M F (2.0 mL) and diisopropylamine
(1.0 mL) provided the crude product. Column chromatography on
silica gel (hexane/ethyl acetate, 40:1) afforded 115 mg (78%) of 3h
as a colourless solid; m.p. 61 °C. 1H NMR (CDCl3, 500 MHz): δ
= 0.02 (s, 9 H, TMS), 1.34 (t, J = 9.0 Hz, 2 H, CH2), 1.44 [s, 9 H,
C(CH3)3], 4.51 (t, J = 9.0 Hz, 2 H, OCH2), 7.35–7.56 (m, 5 H, Ph),
7.60 (s, 1 H, 5-H) ppm. 13C NMR (CDCl3, 126 MHz): δ = –1.4 (q,
TMS), 19.1 (t, CH2), 29.2, 38.6 [q, s, C(CH3)3], 71.8 (t, OCH2),
1
(q, JCF = 275 Hz, CF3), 126.1, 128.4, 128.7, 129.4, 129.5, 129.7,
2
131.9, 136.2, 138.6 (2 s, 6 d, s, C-4, Ph), 142.6 (q, JCF = 35.5 Hz,
C-6), 152.8, 156.5 (2 s, C-2, C-3) ppm. IR (KBr): ν = 3000–2940
˜
(= C–H , C–H), 2220 (CϵC), 1600–1580 (C=C) cm–1. MS (EI,
80 eV, 80 °C): m/z (%) = 353 (100) [M]+, 352 (64) [M – H]+. HRMS
calcd. for C21H14F3NO: 353.10275; found 353.10377.
2-tert-Butyl-4-(hex-1-ynyl)-3-methoxy-6-(trifluoromethyl)pyridine
(3d): According to method A, pyridyl nonaflate 1b (100 mg,
0.188 mmol), Pd(OAc)2 (2.5 mg, 0.013 mmol), PPh3 (10 mg,
0.037 mmol), CuI (1.8 mg, 0.009 mmol), 1-hexyne (46 mg,
0.56 mmol) in DMF (0.8 mL) and diisopropylamine (0.4 mL) pro-
vided the crude product. Column chromatography on silica gel
(hexane/ethyl acetate, 40:1) afforded 36 mg (61%) of 3d as a light
1
84.2, 98.5 (2 s, CϵC), 121.7 (q, JCF = 274 Hz, CF3), 122.1, 124.3
3
(2 s, C-4, i-Ph), 122.8 (qd, JCF = 2.8 Hz, C-5), 128.6, 129.4, 131.6
2
1
(3 d, Ph), 139.8 (q, JCF = 37 Hz, C-6), 156.6, 162.6 (2 s, C-2, C-
yellow oil. H NMR (CDCl3, 500 MHz): δ = 0.94 (t, J = 7.4 Hz, 3
3) ppm. IR (KBr): ν = 3090–3070 (=C–H), 3000–2870 (C–H),
˜
H, Me), 1.39 [s, 9 H, C(CH3)3], 1.43–1.53, 1.60–1.66 (2 m, 2 H
each, CH2), 2.49 (t, J = 7.5 Hz, 2 H, CH2), 4.01 (s, 3 H, OMe),
7.47 (s, 1 H, 5-H) ppm. 13C NMR (CDCl3, 126 MHz): δ = 13.6,
19.5, 22.1, 29.1 (q, 3 t, Bu), 30.4, 38.3 [q, s, C(CH3)3], 60.8 (q,
2235–2210 (CϵC), 1600–1540 (C=C) cm–1. MS (EI, 80 eV, 50 °C):
m/z (%) = 419 (1) [M ]+ , 404 (1) [M – CH 3]+ , 391 (32) [M –
C2H 4]+ , 101 (10) [C2H 4SiC3H 9]+ , 73 (100) [C3H 9Si]+ , 69 (2)
[CF3]+, 57 (6) [C4H9]+. C23H28F3NOSi (419.6): calcd. C 65.84, H
6.73, N 3.34; found C 65.89, H 6.68, N 3.29.
1
OMe), 75.4, 101.5 (2 s, CϵC), 121.6 (q, JCF = 273.5 Hz, CF3),
3
2
123.3 (dq, JCF = 2.9 Hz, C-5), 140.1 (q, JCF = 34.5 Hz, C-6),
125.3, 157.9, 162.4 (3 s, C-2, C-3, C-4) ppm. IR (KBr): ν = 2960–
˜
Typical Procedure for the Preparation of Furo-pyridine Derivatives
(Method B): To a solution of pyridine 3b (200 mg, 0.60 mmol) in
dichloromethane (6 mL) under argon atmosphere was added BBr3
(1 in CH2Cl2, 0.90 mL, 0.90 mmol) dropwise at 0 °C and warmed
up to room temperature. The reaction mixture was monitored by
TLC; upon completion, ice/water was added and the mixture was
extracted with dichloromethane (3ϫ5 mL). The combined organic
layers were washed with water and brine, dried with Na2SO4 and
2870 (=C–H, C–H), 2230 (CϵC), 1590–1540 (C=C) cm–1. MS (EI,
80 eV, 80 °C): m/z (%) = 313 (69) [M]+, 298 (100) [M – CH3]+, 57
(17) [C4H9]+. HRMS: calcd. for C17H22F3NO: 313.16534; found
313.16488.
4-[2-tert-Butyl-3-methoxy-6-(trifluoromethyl)pyridin-4-yl]-2-methyl-
but-3-yn-2-ol (3e): According to method A, pyridyl nonaflate 1b
(1.63 g, 3.06 mmol), Pd(OAc)2 (48 mg, 0.21 mmol), PPh3 (159 mg,
Eur. J. Org. Chem. 2008, 3647–3655
© 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
3651